EMS announces 11% revenue growth in 2024

EMS, a specialist in medical imaging systems, has published a turnover of 45.1 million euros for 2024, marking an increase of 11% compared to 2023. This growth is based on its flagship activities in radiology and bone densitometry, both in France and internationally. Own-label and white-label sales were balanced, representing 48% and 52% of turnover respectively.

The group has invested in the development of new mobile products and solutions. The Onyx mobile, which combines technological innovation and maneuverability, was launched at the Journées Francophones de la Radiologie. In addition, the introduction of the multiplatform ADAM AI strengthens the EMS offer in artificial intelligence, with an international deployment envisaged.

EMS has signed significant agreements in the United States in 2024 that should support future growth. Despite an unstable geopolitical context, the group remains confident in its ability to maintain its growth momentum in 2025.